ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,000 | -86.7% | 2,370 | -83.9% | 0.00% | – |
| Q2 2023 | $98,000 | +22.5% | 14,689 | +62.4% | 0.00% | – |
| Q1 2023 | $80,000 | -50.9% | 9,043 | -57.7% | 0.00% | – |
| Q4 2022 | $163,000 | +328.9% | 21,388 | +298.5% | 0.00% | – |
| Q3 2022 | $38,000 | -7.3% | 5,367 | +4.9% | 0.00% | – |
| Q2 2022 | $41,000 | -63.1% | 5,117 | -36.2% | 0.00% | – |
| Q1 2022 | $111,000 | -22.9% | 8,017 | +56.2% | 0.00% | – |
| Q4 2021 | $144,000 | -27.6% | 5,132 | -12.5% | 0.00% | – |
| Q3 2021 | $199,000 | -21.7% | 5,862 | -5.6% | 0.00% | – |
| Q2 2021 | $254,000 | -58.4% | 6,212 | -59.0% | 0.00% | – |
| Q1 2021 | $611,000 | +627.4% | 15,158 | +962.2% | 0.00% | – |
| Q4 2020 | $84,000 | +110.0% | 1,427 | +75.3% | 0.00% | – |
| Q3 2020 | $40,000 | -98.6% | 814 | -98.7% | 0.00% | -100.0% |
| Q2 2020 | $2,952,000 | +69.6% | 61,003 | -2.7% | 0.00% | 0.0% |
| Q1 2020 | $1,741,000 | +1972.6% | 62,682 | +2144.3% | 0.00% | – |
| Q4 2019 | $84,000 | -75.6% | 2,793 | -75.0% | 0.00% | – |
| Q3 2019 | $344,000 | +17.4% | 11,179 | +84.6% | 0.00% | – |
| Q2 2019 | $293,000 | – | 6,055 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |